HOME › DRUGS › RELATLIMAB-RMBW
ACTIVE SUBSTANCE / INN

RELATLIMAB-RMBW

Brand name(s): OPDUALAG
FDA LISTED
PRESCRIPTION
BLA761234
ACTIVE SUBSTANCE
Relatlimab-Rmbw
REGULATORS
FDA
SPONSORS / MAH
BRISTOL MYERS SQUIBB
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OPDUALAGBLA761234BRISTOL MYERS SQUIBBPrescription

FULL INTELLIGENCE ON RELATLIMAB-RMBW

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →